What is the unit price and course cost of selumetinib as a targeted drug?

Selumetinib (Selumetinib) is a targeted therapy drug mainly used to treat specific diseases such as neurofibromatosis. The drug has been successfully launched in China and has been included in the medical insurance system. Patients can purchase it through regular hospitals or pharmacies. The implementation of this policy has greatly facilitated patients' medication use and effectively reduced the burden of treatment.

At present, the unit price of selumetinib in China is approximately more than 10,000 yuan per box, and the specific price will vary depending on the region, hospital and medical insurance policy. Since it has been included in medical insurance, patients can enjoy a certain proportion of reimbursement when actually paying, but the specific reimbursement amount and proportion require patients to consult the local hospital pharmacy to obtain accurate information.

From the perspective of treatment cost, the medication cycle of selumetinib varies depending on the condition and doctor’s plan. Generally, the cost of a complete course of treatment may reach tens of thousands of yuan. Despite this, considering its strong pertinence and obvious efficacy, many patients and doctors still believe that it is cost-effective and an important choice for the treatment of related diseases.

In addition, there is a more affordable Laotian generic version on the foreign market, with a unit price of about 2,000 yuan, and the drug ingredients are basically the same as the domestic original drugs. For patients with greater financial pressure, they can consider purchasing such generic drugs through formal channels, but it is recommended to make reasonable choices under the guidance of professional doctors to ensure drug safety and therapeutic effect.

Reference materials:https://www.drugs.com/